increased leukemia incidence_Dok2<tm1Ppp>/Dok2<tm1Ppp>,Tg(BCR/ABL1)5Hhi/0

http://metadb.riken.jp/0002026I129S1SvDok2tm1PppDok2tm1PppTgBCRABL15Hhi0Dok2tm1PppTgBCRABL15Hhi

increased leukemia incidence_Dok2<tm1Ppp>/Dok2<tm1Ppp>,Tg(BCR/ABL1)5Hhi/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• docking protein 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1332623
• transgene insertion 5, Hisamaru Hirai
  http://metadb.riken.jp/db/mgi_rdf/MGI:3039035

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Dok2<tm1Ppp>/Dok2<tm1Ppp>,Tg(BCR/ABL1)5Hhi/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Dok2<tm1Ppp>|Tg(BCR/ABL1)5Hhi

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased leukemia incidence
  http://purl.obolibrary.org/obo/MP_0002026

文献

http://purl.org/net/cito/citesAsAuthority

• Masaru. Niki, et.al., Role of Dok-1 and Dok-2 in leukemia suppression., The Journal of experimental medicine, 2004, 200
  http://rdf.ncbi.nlm.nih.gov/pubmed/15611295